Evidence-Based Medicine Guidelines
Ipratropium as an adjunct to beta2 agonists for acute asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ipratropium as an Adjunct to Beta2 Agonists for Acute Asthma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456959/all/__________Ipratropium_as_an_adjunct_to_beta2_agonists_for_acute_asthma______.
Ipratropium as an adjunct to beta2 agonists for acute asthma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456959/all/__________Ipratropium_as_an_adjunct_to_beta2_agonists_for_acute_asthma______. Accessed May 14, 2025.
Ipratropium as an adjunct to beta2 agonists for acute asthma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456959/all/__________Ipratropium_as_an_adjunct_to_beta2_agonists_for_acute_asthma______
Ipratropium as an Adjunct to Beta2 Agonists for Acute Asthma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456959/all/__________Ipratropium_as_an_adjunct_to_beta2_agonists_for_acute_asthma______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ipratropium as an adjunct to beta2 agonists for acute asthma
ID - 456959
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456959/all/__________Ipratropium_as_an_adjunct_to_beta2_agonists_for_acute_asthma______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
